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proteins were tested for inhibitory activity on trypsin, 
eleven pharmacological relevant proteases and the non-pro-
teolytic enzyme 5-lipoxygenase. Members of the KTI and 
PIN families inhibited pig pancreas elastase, β-Secretase, 
Cathepsin K, HIV-1 protease and potato 5-lipoxygenase. 
Our results demonstrate in vitro inhibitory diversity of 
small potato tuber proteins commonly known as protease 
inhibitors, which might have biotechnological or medical 
applications.
Keywords Potato (Solanum tuberosum L.) · Tuber · 
Enzyme inhibitor · Protease inhibitor · Heterologous 
expression · Pichia pastoris
Introduction
Protease inhibitors (PIs) are ubiquitous, small proteins 
which are particularly abundant in plant reproductive and 
storage organs such as seeds and tubers (Ryan 1990). They 
account for 1–10 % of the total protein in storage tissues. 
In higher plants, several PI families have been character-
ized for their molecular structure and biochemical function. 
The structural basis of the interaction between proteases 
and their inhibitors is under continuous investigation (Bate-
man and James 2011; Mosolov and Valueva 2005). PIs are 
involved in many physiological processes via control of 
protease activity. The best characterized example is their 
role in wound-induced defense responses of plants against 
herbivores and pathogens (Hartl et al. 2011; Jorgensen 
et al. 2006). They are also considered as storage proteins 
(Ryan 1990).
Potato tuber protein consists mainly of patatin, the major 
storage protein, and numerous low molecular weight PIs 
which can be classified in at least ten different families 
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(De Leo et al. 2002; Rawlings et al. 2008). Most abun-
dant are inhibitors of serine proteases from families known 
as Kunitz-type inhibitors (KTI), potato protease inhibi-
tors I and II (PIN I, PIN II) and Bowman–Birk inhibitors 
(BBIs). KTIs are one of the best characterized inhibitors. 
These vacuolar proteins are abundant in potato tubers 
and represent a highly diverse group of proteins (Heibges 
et al. 2003a). Most KTIs are encoded at a complex locus 
on potato chromosome III, which is linked to a quantita-
tive trait locus (QTL) for resistance to the oomycete Phy-
tophthora infestans (Heibges et al. 2003a; Odeny et al. 
2010). Most KTIs consist of a single polypeptide chain 
of approximately 24 kDa with two disulfide bridges and 
a single reactive site. Depending on the cultivar studied, 
potato KTIs were classified in three to six structural sub-
groups (A, B, C, D, K and M) (Bauw et al. 2006; Heibges 
et al. 2003a; Ishikawa et al. 1994; Oliva et al. 2010). The 
tremendous structural variability among KTIs suggested 
functional diversity (Heibges et al. 2003b). Previous stud-
ies revealed that KTIs have distinct target specificities in 
vitro and some have dual or broad specificity. Inhibitors 
of subgroup KTI-A reduced the activity of serine or aspar-
tic proteases such as trypsin or cathepsin D (Heibges et al. 
2003b; Ishikawa et al. 1994). Members of subgroup KTI-B 
inhibited trypsin, chymotrypsin or elastase and members of 
subgroup KTI-C inhibited not only subtilisin and cysteine 
proteases, but also other enzymes like invertase (Glacz-
inski et al. 2002; Heibges et al. 2003b). Similar to KTIs, 
the PIN I and PIN II families display high structural and 
functional diversity, particularly in the Solanaceae, and are 
organized as gene clusters mainly on potato chromosome 
IX and III, respectively. Plant PINs have been character-
ized at the biochemical and molecular level. PIN I protein 
was first isolated from potato tubers (Balls and Ryan 1963). 
More recent studies demonstrated PIN I expression in 
leaves, stems, flowers and tuber sprouts, which is regulated 
by both environmental and developmental signals (John-
son and Ryan 1990; Turra et al. 2009; Valueva et al. 2003). 
Proteins homologous to PIN I are found in several plant 
species such as barley or maize, while PIN II’s seem to be 
restricted to the Solanaceae (Mosolov and Valueva 2005). 
PIN proteins are suggested to function in plant interactions 
with herbivores and microbes. Digestive enzymes in the 
guts of herbivores were inhibited by plant PINs, restricting 
the absorption of essential amino acids and consequently 
interfering with herbivore growth and development (Chen 
2008). In vitro assays confirmed inhibitory effects of plant 
PINs on the digestive serine proteases trypsin, chymot-
rypsin or subtilisin (Hartl et al. 2010; Mosolov and Valueva 
2005; Turra et al. 2009).
The detrimental effect observed on herbivores and pests 
led to the development of inhibitor-transgenic plants (Chen 
2008; Dunse et al. 2010). However, due to the adaptation 
of herbivores by maintaining diverse digestive enzymes 
and over-expressing inhibitor insensitive enzymes, and 
last but not least due to the rejection of transgenic crops 
by the public, transgenic approaches have not been widely 
adopted in commercial food crops (Jongsma and Bolter 
1997; Zhu et al. 2005). Beyond plant biotechnology, plant 
PIs became attractive targets in pharmacology and drug 
development. Inhibitors of KTI and BBI families, puri-
fied from different leguminous seeds, were shown to block 
the activity of several proteases and enzymes involved in 
human diseases (reviewed in (Oliva and Sampaio 2009)). 
Plant KTIs inhibited proteins acting in the blood clotting 
cascade or in fibrinolysis such as factor XIIa, factor Xa, 
thrombin, plasmin, plasma kallikrein or tissue plasminogen 
activator (Cruz-Silva et al. 2004; Oliva and Sampaio 2008; 
Oliva et al. 2000). Elastase and cathepsin G involved in 
inflammatory processes in humans were shown to be inhib-
ited by KTIs isolated from Bauhinia seeds (Neuhof et al. 
2003; Oliveira et al. 2010). Several studies revealed anti-
tumor activity of BBI and KTI inhibitors (Oliva and Sam-
paio 2009; Oliva et al. 2010). Trypsin inhibitors from Pelto-
phorum dubium (PDTI) and soybean induced cell death of 
human leukemic Jurkat cell lines by activation of caspases 
3 and 8. Inhibitors from seeds of the Chinese black soy-
bean Glycine max suppressed cell proliferation of MCF-7 
breast cancer cells and HepG2 hepatoma cells. Peptides 
derived from Bauhinia rufa trypsin Inhibitor (BrTI) inhib-
ited the adhesion of tumor cells to extracellular matrix gly-
coproteins (Nakahata et al. 2006). In summary, KTI effects 
were investigated in inflammation, thrombosis, AIDS (auto 
immune deficiency syndrome), parasitic diseases and anti-
fungal activity (Oliva et al. 2010).
In this paper, we tap at the tremendous structural diver-
sity of proteinaceous inhibitors found in tubers of different 
potato genotypes and their potential inhibitory functions. 
Novel variants of KTI, PIN I, PIN II and other types of pro-
teinaceous inhibitors were isolated as full length cDNAs 
from tubers of ten different potato varieties. A subset was 
expressed as recombinant fusion proteins in the yeast 
Pichia pastoris and examined for inhibitory properties on 
serine, cysteine and aspartic proteases involved in human 
diseases including Alzheimer disease, AIDS and osteoporo-
sis, as well as on the potato enzyme lipoxygenase.
Materials and methods
Plant material
Field grown tubers from nine potato varieties (Lady Claire, 
Omega, Eurobeta, Verdi, Elfe, Marabel, Allians, Solara, 
Melba) and one breeding clone (Breeding clone 18) were 
provided by EUROPLANT Pflanzenzucht GmbH (Ebstorf, 
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Germany). Tubers were peeled, washed and snap frozen in 
liquid nitrogen. Tuber tissue was homogenized by Mixer 
Mill MM 200 (Retsch, Haan, Germany) and stored at 
−80 °C until use.
cDNA libraries
Total RNA was isolated from 5 g powdered, frozen tuber 
tissue using the PureLink® Plant-RNA reagent (Invitro-
gen™, Carlsbad, USA) according to the manufacturer’s 
guidelines. Poly A+ RNA was prepared from total RNA 
using the Poly(A)Purist™ MAG purification kit (Ambion®, 
Austin, USA) following the suppliers instructions. Ten 
cDNA libraries were constructed from Poly A+ RNA of the 
ten genotypes. cDNA synthesis and transformation of Elec-
tromax™ DH10B™ T1 Phage resistant E. coli cells were 
performed using to the CloneMiner™ II cDNA Library 
construction kit (Invitrogen™, Carlsbad, USA) and the 
supplier’s protocol. 960 cDNA clones per library were ran-
domly selected (9,600 clones total) and stored in 96-well 
microtiter plates.
cDNA sequence analysis
Plasmid insertions were sequenced from the 5′ end using 
a primer (5′GTAAAACGACGGCCAGT3′) matching to the 
M13-forward (−20) priming site of the pDONR™222 vec-
tor which was used for cDNA library construction. Custom 
DNA Sanger-sequencing was performed at the Max-Planck 
Genome Center [Cologne, Germany (http://mpgc.mpipz.
mpg.de/home/)]. Inhibitor sequences were identified by 
BLAST comparisons to the NCBI nucleotide collection 
(NR/NT). cDNA clones coding for various inhibitors of 
proteases and other enzymes were selected and sequenced 
from the 3′ end using a primer (5′AACAGCTATGAC 
CATG3′) specific for the M13-reverse priming site to 
identify full length cDNA clones. Recombinant E. coli 
clones harboring inhibitor sequences were propagated in 
LB-media (1 % Tryptone, 0.5 % yeast extract, 1 % NaCl, 
pH 7) containing 50 µg/ml kanamycin. Plasmid DNA was 
isolated using the Plasmid Mini Kit (QIAGEN®, Hilden, 
Germany) according to the manufacturer’s guidelines and 
stored at −20 °C.
Heterologous expression of cDNAs encoding protease 
inhibitors
cDNAs encoding mature protease inhibitors were cloned 
into the multiple cloning sites (MCS) of the expression 
vector pPICZαA (Invitrogen™, Carlsbad, USA) without 
their putative signal sequences. Putative signal sequences 
were identified using SignalP 4.0 software (http://www.
cbs.dtu.dk/services/SignalP/). Translation termination 
sequences were omitted in fusing inhibitor sequences with 
the c-myc epitope and His-tag of the pPICZαA vector. 
Expression of fusion proteins was controlled by the metha-
nol-inducible AOX1 promoter. The native α-factor secretion 
signal sequence from Saccharomyces cerevisiae allowed 
secretion of the fusion protein into the medium. For expres-
sion cloning, inhibitor sequences were amplified by PCR 
using 1 ng plasmid DNA as template and the primers speci-
fied in Table 1. PCR conditions were: 95 °C for 5 min, fol-
lowed by 20 cycles of 95 °C for 1 min, 60 °C for 1 min and 
72 °C for 1.5 min with a final extension step at 72 °C for 
5 min. Cloning of PCR products into the pPICZαA vector 
and transformation of Pichia pastoris cells (strain GS115) 
was accomplished with the EasySelect™ Pichia Expression 
Kit (Invitrogen™, Carlsbad, USA) according to the suppli-
ers protocol. Nucleotide sequences were verified by direct 
sequencing.
Expression of recombinant proteins
Recombinant P. pastoris—strains expressing a specific 
inhibitor were pre-cultured by inoculating 100 ml BMGY 
medium (1 % yeast extract, 2 % peptone, 100 mM potas-
sium phosphate pH6, 1.34 % yeast nitrogen base, 0.0004 % 
biotin, 1 % glycerol) with a single colony. Cultures were 
incubated with continuous shaking at 28 °C for 24 h. Cells 
were harvested by centrifugation at 2,000×g for 10 min and 
re-suspended to an OD600 = 1 in 500 ml BMMY medium 
(1 % yeast extract, 2 % peptone, 100 mM potassium phos-
phate pH 6, 1.34 % yeast nitrogen base, 0.0004 % biotin, 
0.5 % MeOH) to induce expression. P. pastoris cells were 
incubated for 72 h at 28 °C with continuous shaking. Every 
24 h 100 % Methanol was added to a final concentration of 
0.5 % to maintain induction. Cells were harvested by cen-
trifugation for 10 min and 3,000×g. The supernatants were 
transferred to a new tube and subsequently used for protein 
purification.
Purification of heterologous expressed inhibitors
Solid ammonium sulfate was added to the supernatant 
of the Pichia pastoris cell culture to a final concentra-
tion of 40 % and stirred for 30 min at room temperature 
(RT). After centrifugation at 10,000×g for 15 min at 4°, 
the pellet was dissolved in 5 ml binding buffer (0.02 M 
NaH2PO4, 1 M NaCl, 0.04 M imidazole, 5 % glycerol, 
pH 7.5). The protein solution was filtered through a 
syringe-attached 0.45 µm filter and loaded onto a 5 ml 
Protino® Ni–NTA column (Macherey–Nagel, Düren, 
Germany) attached to an Äkta Prime Plus (GE Health-
care, Little Chalfont, UK) chromatographic system. 
The column was washed with 150 ml binding buffer to 
remove unbound proteins. The His-tagged fusion protein 
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was eluted with 10 ml 0.02 M NaH2PO4, 1 M NaCl, 
0.25 M imidazole, 5 % glycerol, pH 7.5. Fractions con-
taining the fusion protein were combined and the elution 
buffer was replaced with 0.01 M Tris/HCl pH 7.5, 5 % 
glycerol using PD-10 desalting columns (GE Healthcare, 
Little Chalfont, UK) according to the manufacturer’s 
guidelines. Eluted fusion protein was concentrated ten-
fold by ultrafiltration using Amicon® Ultra centrifugal 
filters (Millipore, Billerica, MS, USA). Protein con-
centration was estimated using Qubit® Protein Assay 
(Invitrogen™, Carlsbad, USA) and BSA (bovine serum 
albumin) as standard. Proteins were snap frozen in liq-
uid nitrogen and stored at −80 °C. Purification of fusion 
proteins was checked on SDS-PAGE using Anykd™ 
mini-protean® TGX™ precast polyacrylamide gels (Bio-
Rad, Hercules, California, USA) according to the manu-
factures guidelines. Western blot analysis was performed 
using 10 ng of purified protein and anti-c-myc antibody 
(Sigma Aldrich, St. Louis, MO, USA) following the pro-
tocol supplied with the antibody.
Enzyme inhibition assays
All inhibition assays were performed with purified recom-
binant inhibitor protein on commercially available enzymes 
using colorimetric assays. Enzymes were pre-incubated 
without inhibitor protein (control) and with single and dou-
ble amounts of inhibitor protein as specified below. After 
pre-incubation, the enzymatic reactions were started by 
adding the substrate. Absorbance was recorded in a micro-
plate reader (Synergy 4, BioTek, Winooski, VT, USA) and 
used to calculate the residual enzyme activity. Enzyme 
inhibition was expressed as percentage of the enzyme activ-
ity in the controls (100 %). In a first round of experiments, 
three to five inhibitors were pooled in different molar ratios 
of inhibitor and enzyme and tested for enzyme inhibition. 
In case inhibitory activity of a pool on the tested enzyme 
was detected, the inhibitors composing the pool were re-
tested individually and values for the half maximal inhibi-
tory concentration (IC50) were calculated. IC50 values of 
active inhibitors were determined in triplicate by plotting 
Table 1  Primer sequences for expression cloning of 23 potato protease inhibitors in pPICZαA
a
 Underlined sequences are the restriction enzyme recognition sites used for cloning in pPICZαA. GAATTC is recognized by EcoRI, CACGTG 
by PmlI and GCGGCCGC by NotI
Type Inhibitor Forward primer (5′–3′)a Reverse primer (5′–3′)a























KTI-C PI1410 AAAGAATTCATGCTTGTACTCCCTGAAGTTTATG AAAGCGGCCGCCGCCTTGATGAACACAAATG
PI4202 AAAGAATTCATGCTTGTACTCCCTGAAGTTTATGACC AAAGCGGCCGCCGCCTTGATGAACACAAATG
PI5446 AAACACGTGCGAAAAGAAAGTGATGGACTAGAAG AAAGCGGCCGCACCAACCACAGGAATTTGTACA
PIN I PI0234 AAAGAATTCATGCGAAAAGAATGTGATGG AAAGCGGCCGCACCAACCACAGGCATTGATAC
PI6013 AAAGAATTCAGAGATTTGATCAGTGATGGCAT AAAGCGGCCGCACCCATACTGGGAGGAATTTG
PIN II PI4434 AAAGAATTCATGAAGGCTTGCACTTTAGAATG AAAGCGGCCGCCATTGCAGGGTACATATTTGCC
PI6669 AAAGAATTCATGAAGGCTTGCACTTTAGAATG AAAGCGGCCGCCATTGCAGGGTACATATTTGCC
PMEI PI7531 AAAGAATTCATGGCGGGTAACGCC AAAGCGGCCGCATGATTTGCAGCATATTGGTT
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percent initial activity against inhibitor concentrations from 
0 to 8 µM in independent experiments.
Trypsin: Trypsin (EC 3.4.21.4) was purchased from 
Sigma Aldrich (St. Louis, USA). The trypsin inhibition 
assay was performed according to (Heibges et al. 2003b) 
with minor modifications using azocasein as substrate. 
Trypsin stock solution (5 mg/ml) was prepared in a buffer 
containing 50 mM Tris/HCl pH 7.5 and 20 mM CaCl2. 
5 µg trypsin (0.21 µM) was pre-incubated for 10 min at 
RT either without (control), or with 0.5 and 1 µM purified 
inhibitor in 40 µl 100 mM Tris/HCl pH 7.5, 40 mM CaCl2. 
After adding 40 µl 2 % azocasein, the reactions were 
mixed by pipetting and incubated for 1 h at RT. Reactions 
were stopped by adding 80 µl 12 % TCA and incubation 
for 30 min at RT. Precipitate was removed by centrifuga-
tion and 100 µl supernatant was transferred to a 96-well 
plate. 50 µl 4 N NaOH were added and the absorbance at 
440 nm was measured.
Elastase: Porcine pancreas elastase (PPE, EC 3.4.21.36) 
was supplied as part of the EnzChek® Elastase Assay Kit 
(Invitrogen™, Carlsbad, USA). Human leukocyte elastase 
(HLE, EC 3.4.21.37) was purchased from Sigma Aldrich 
(St. Louis, USA). HLE was reconstituted with dH2O to 
1U/µl. PPE and HLE were diluted to 0.2 U/ml in 100 µl 
assay buffer (100 mM Tris/HCl pH 8, 0.2 mM sodium 
azide) included in the EnzChek® Elastase Assay Kit, and 
incubated for 10 min at RT with either none (control), 200 
or 400 nM inhibitor protein. Elastase activity was deter-
mined according to the assay kit manufacturers’ guidelines 
including elastase inhibitor control reactions. Fluorescence 
intensity of inhibitor samples was corrected for background 
fluorescence determined from samples without enzyme.
Dipeptidylpeptidase 4 (DPP4): Screening for DPP4 (EC 
3.4.14.5) inhibitors was performed using the DPP4 Drug 
Discovery Kit (Enzo® Life Sciences, Farmingdale, New 
York, USA) according to the manufacturer‘s guidelines. 
DPP4 activity was detected using the chromogenic (H-Gly-
Pro-pNA) substrate supplied with the kit. DPP4 was pre-
incubated for 10 min at 37 °C with either none (control), 
100 or 200 nM inhibitor protein. The assay was started by 
adding the substrate and the absorption at 405 nm was con-
tinuously read. A 405 nm values were plotted versus time 
until 15 min after addition of the substrate and a regression 
line was obtained. The slope was used to calculate DPP4 
activity.
Factor IXa: Factor IXa (EC 3.4.21.22) was purchased 
from Abcam® (Cambridge, UK) and was diluted to 90 ng/µl 
in assay buffer (50 mM Tris/HCl pH 7.4, 100 mM NaCl, 
5 mM CaCl2, 40 % ethylene glycol). 20 µl of diluted enzyme 
solution was pre-incubated for 15 min at 37 °C with 200 µl 
assay buffer containing none (control), 50 or 100 nM pro-
tease inhibitor in a 96-well plate. The enzymatic reaction 
was initiated by adding 25 µl of 10 mM substrate solution 
(Pefachrome® FIXa, Pentapharm, Basel, Switzerland) and 
increase in absorbance at 405 nm was recorded for 15 min 
at 37 °C. A linear regression was fitted to the linear propor-
tion of the absorbance curve and the slope was calculated. 
The background slope determined from samples without 
enzymes was subtracted from enzyme and inhibitor samples.
Factor Xa: Factor Xa (EC 3.4.21.6) was purchased from 
Merck KGaA (Darmstadt, Germany) and was diluted to 
5 ng/µl in assay buffer (50 mM Tris/HCl pH 7.4, 300 mM 
NaCl, 200 µg/ml BSA). 10 µl of diluted enzyme solution 
was incubated for 10 min at 37 °C in 80 µl assay buffer 
including either none (control), 10 or 20 nM inhibi-
tor in a 96-well plate. 10 µl of 4 mM substrate solution 
(Pefachrome® FXa, Pentapharm, Basel, Switzerland) was 
then added and the increase in absorbance at 405 nm for 
5 min at 37 °C was recorded. A linear regression was fit-
ted to the linear proportion of the absorbance curve and the 
slope was calculated. The background slope determined 
from samples without enzyme was subtracted from control 
and inhibitor samples.
Thrombin: Thrombin from human plasma (EC 3.4.21.5) 
was purchased from Sigma Aldrich (St. Louis, USA).
Thrombin enzyme solution was diluted in assay buffer 
(10 mM HEPES pH 7.5, 150 mM NaCl, 200 µg/ml BSA) 
to 7.5 ng/µl. 10 µl diluted enzyme solution was incu-
bated for 10 min at 37 °C either without (control) or with 
20 and 40 nM purified inhibitor in 80 µl assay buffer in a 
96-well plate. After adding 20 µl substrate solution (0.5 mg/
ml N-Benzoyl-L-phenylalanyl-L-valyl-l-arginine-4-ni-
troanilide. Merck KGaA, Darmstadt, Germany) release 
of ρ-nitroanilide (ρNA) was monitored by the increase 
in absorbance at 405 nm for 5 min at 37 °C. Background 
absorption was determined from reaction mixtures without 
enzyme. A linear regression was fitted to the increase in 
absorbance and the enzyme activity was calculated from the 
slope. The slope of the background was subtracted from the 
slope of control measurements and the inhibitor samples.
β-Secretase (BACE-1): Screening for BACE (EC 
3.4.23.46) inhibitors was performed using the BACE Inhib-
itor Screening assay kit (Cayman Chemical Company, Ann 
Arbor, MI, USA) according to the manufacturer’s instruc-
tions. BACE was pre-incubated for 15 min at 4 °C with 
either none (control), 100 or 200 nM inhibitor protein.
HIV1-Protease: Screening for HIV-1 protease (EC 
3.4.23.16) inhibitors was performed using the Sensolyte® 
490 HIV1 Protease Assay Kit (Ana Spec, Fremont, CA, 
USA) according to the manufacturer’s guidelines. HIV-1 
protease was purchased from Ana Spec (Fremont, CA, 
USA) and was diluted to 10 ng/µl (125 nM) with assay 
buffer complemented with Dithiothreitol (DTT) supplied 
with the kit. HIV-1 protease was pre-incubated for 15 min 
at room temperature with either none (control), 100 or 
200 nM inhibitor protein.
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Human Calpain-1: Screening for human calpain-1 (EC 
3.4.22.52) inhibitors was performed using the Sensolyte® 
AMC Calpain Activity Assay (Ana Spec, Fremont, CA, 
USA) according to the manufacturer’s protocol. Human cal-
pain-1 (supplied with the kit) was pre-incubated for 5 min at 
37 °C with none (control), 100 or 200 nM inhibitor protein.
Caspase-1: Screening for human Caspase-1 (EC 
3.4.22.36) inhibitors was performed using the Caspase-1 
Drug Discovery Kit (Enzo® Life Sciences, Farmingdale, 
New York, USA) according to the manufacturer’s guide-
lines. Caspase-1 activity was detected using the chromoge-
nic (AC-YVDA-pNA) substrate supplied with the kit. Cas-
pase-1 was pre-incubated for 10 min at 30 °C with either 
none (control), 100 or 200 nM inhibitor protein. The assay 
was started by adding the substrate and the absorption at 
405 nm was continuously read for 30 min. A 405 nm values 
were plotted versus time until 15 min after addition of the 
substrate and a regression line was obtained. The slope was 
used to calculate Caspase-1 activity.
Cathepsin K: Screening for Cathepsin K (EC 3.4.22.38) 
inhibitors was performed using the Cathepsin K Drug Dis-
covery Kit (Enzo® Life Sciences, Farmingdale, New York, 
USA) according to the manufacturer’s guidelines. Cathep-
sin K was pre-incubated for 30 min at 37 °C with either 
none, 100 or 200 nM inhibitor protein.
Matrix-Metalloproteinase-P9 (MMP-9): Screening for 
MMP-9 (EC 3.4.24.35) inhibitors was performed using 
the MMP-9 colorimetric drug discovery kit (Enzo® Life 
Sciences, Farmingdale, New York, USA) according to the 
manufacturer’s guidelines. MMP-9 was pre-incubated for 
30 min, at 37 °C with either none (control), 200 or 400 nM 
inhibitor protein.
5-Lipoxygenase (5-Lox): Lipoxygenase (EC 1.13.11.34) 
activity was assayed using the Lipoxygenase Inhibitor 
Screening Assay Kit (Cayman Chemical Company, Ann 
Arbor, MI, USA) according to the manufactures guidelines. 
5-Lipoxygenase from Solanum tuberosum (potato) was 
purchased from Cayman Chemical Company (Ann Arbor, 
MI, USA). Linolenic acid was used as substrate. Residual 
5-Lox activity was determined after pre-incubation for 
15 min at 4 °C with either none (control), 200 or 400 nM 
protease inhibitor. Data analysis was performed according 
to the instructions supplied with the assay kit.
Results
Isolation of novel inhibitor variants from tuber cDNA 
libraries
In total 9,600 cDNA clones were randomly selected from 
small libraries prepared from mature tuber mRNA of ten 
potato genotypes (960 ESTs/cDNA library) and sequenced. 
One-hundred and seventy-five mostly full length cDNA 
clones encoding various inhibitor types were identi-
fied based on sequence similarity to known inhibitors in 
the GenBank core collection. After the removal of dupli-
cate sequences, 120 unique inhibitor sequences remained, 
which matched to 31 loci in the potato genome (Fig. 1, 
supplemental Table 1). The deduced polypeptide sequence 
of 88 inhibitors (73 %) differed between 1 % and 18 % 
from inhibitor sequences present in the GenBank core col-
lection. The nucleotide sequences fell into 19 structural 
groups with the largest group corresponding to Kunitz-type 
inhibitors A and B (supplemental Table 1). The Kunitz-
type protease inhibitor (KTI) family accounted for 52 % of 
the inhibitor collection. The KTI family is divided into six 
structural groups (A, B, C, D, M and K) (Speranskaya et al. 
2012), four of which were represented in the inhibitor col-
lection (A, B, C and D). Fourteen KTIs assigned to group 
A (KTI-A), 33 in group B (KTI-B),12 in group C (KTI-C) 
and 4 in group D (KTI-D) matched to two, one, three and 
two loci, respectively, in the potato genome (PGSC 2011)
(supplemental Table 1, Fig. 1).The second largest group 
corresponded to the potato protease inhibitor (PIN) family. 
PINs are divided in two structural groups. Accordingly, 9 
and 8 cDNAs were classified as members of the subfami-
lies PIN I and PIN II, respectively. The 17 PINs matched to 
three loci. Nine sequences were assigned to pectin methy-
lesterase inhibitors (PMEI) derived from three loci. Seven 
cDNAs each were identified as metallocarboxypeptidase 
inhibitors and defensins or Gamma-thionins. The remain-
ing 17 cDNAs were classified in other inhibitor families 
like BAX, RNase E and putative phosphatase 2A (PPA 2A) 
inhibitors.
Inhibitor heterologous expression and purification
Twenty-nine inhibitors were selected for functional char-
acterization of fusion proteins expressed in Pichia pasto-
ris (supplemental Figure 1). The majority of the inhibitors 
were chosen based on previously described pharmacologi-
cal properties of representatives of the KTI and PIN fami-
lies. The major KTI structural groups A, B and C were 
represented by seven, twelve and three inhibitor variants, 
respectively. The PIN family was represented by two inhib-
itors each of the PIN I and PIN II sub-family. In addition 
to the KTI and PIN representatives, one PMEI, one RNase 
E and the unique ‘Cyclin dependent kinase inhibitor 2′ 
were selected. The sequences corresponding to the mature 
inhibitor polypeptides of 23 inhibitors (5 KTI-A, 10 KTI-
B, 3 KTI-C, 2 PIN I, 2 PIN II, 1 PMEI) were successfully 
expressed in Pichia pastoris. Expression of seven inhibi-
tors could not be detected in the P. pastoris system. Fusion 
proteins were purified from the culture medium by affinity 
chromatography. As an example, purification of the KTI-C 
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inhibitor PI1410 is shown in Fig. 2. Following SDS-PAGE 
a faint band of 23 kDa was visible in the P.pastoris growth-
media corresponding to the expected size of the fusion pro-
tein (Fig. 2a, Lane 1). Further purification by ammonium 
sulfate precipitation and affinity chromatography resulted 
in an enrichment of the 23 kDa protein band (Fig. 2a, Lane 
3). The purified fusion protein was identified by Western 
blot analysis using a myc-tag antibody as probe (Fig. 2b, 
Lane 1). All 23 inhibitors were expressed in P. pastoris 
cells as described for PI1410 and expression was verified 
by Western blot analysis (data not shown). Inhibition assays 
were carried out using the purified inhibitor fusion protein.
Fig. 1  Physical map of genes encoding potato proteinaceous enzyme 
inhibitors. Genomic positions are according to the potato pseudomol-
ecules (version 4.03) at http://potato.plantbiology.msu.edu/cgi-
bin/gbrowse/potato/. Locus identifiers are shown to the right and 
names of encoded inhibitors are shown to the left of the chromo-
somes. Further details are shown in supplemental Table 1. NA: the 
locus is not annotated in the potato genome
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Protease and enzyme inhibition by recombinant inhibitor 
proteins
Purified inhibitor proteins were tested for in vitro inhibition 
of the serine proteases trypsin, elastase (pig pancreas, PPE, 
human leukocyte, HLE), dipeptidylpeptidase IV (DPP IV), 
factor IXa (FIXa), factor Xa (FXa) and thrombin. Four 
inhibitors (PI6033, PI0875, PI6362, PI0234) did not show 
any inhibitory activity on any of the enzymes tested (not 
shown). The serine proteases HLE, DPP IV, FIXa, FXa and 
thrombin, the cysteine proteases Calpain-1, Caspase-1 and 
the matrix-metallopeptidase-9 (MMP-9) were not affected 
by any of the tested inhibitors (not shown). Many inhibitors 
from the KTI, PIN and PMEI families are known to inhibit 
trypsin (Bauw et al. 2006; Heibges et al. 2003b; Jorgensen 
et al. 2006; Pouvreau et al. 2001). Trypsin inhibition 
among and within the inhibitor families was highly diverse, 
ranging from 0 to 87 % inhibition (Table 2). Among the 
KTIs, trypsin was inhibited primarily by members of sub-
group B and percent inhibition varied from 16 % (PI8311) 
to 83 % (PI5918) (Table 2). KTI-A and KTI-C inhibitors 
had no or minor inhibitory effects on trypsin. Three PINs 
showed inhibitory properties comparable to KTI-B proteins 
(Table 2). The representative of the PMEI family (PI7531) 
showed only mild trypsin inhibition (10 %). Both PIN II 
inhibitors PI4434 and PI6669 inhibited the pig pancreas 
elastase with IC50 values of 0.67 µM and 0.97 µM, respec-
tively (Table 2). Furthermore, the fusion proteins were 
tested for inhibition of the aspartyl proteases β-secretase 
(BACE) and HIV-1 protease. Inhibitors related to KTI-B 
and KTI-C subfamilies were responsible for BACE inhi-
bition when tested individually. The KTI-B inhibitors 
PI8234, PI2112, PI5887 and PI4587 and the KTI-C inhibi-
tor PI5446 strongly inhibited BACE with IC50 values 
between 0.36 µM and 0.81 µM (Table 2). HIV-1 protease 
was inhibited by the PIN I inhibitor PI6013 with an IC50 
value of 0.67 µM (Table 2). The cysteine protease Cathep-
sin K was effectively inhibited by all three KTI-Cs tested 
(PI410, PI5446, PI4202) and by the PIN I inhibitor PI6013, 
which in addition inhibited the HIV-1 protease (Table 2). 
The KTI-C inhibitors with IC50 values between 0.02 
and 0.09 µM were more effective than the PIN I inhibitor 
with an IC50 value of 0.77 µM. 5-Lipoxygenase was the 
only non-proteolytic enzyme tested. 5-Lipoxygenase was 
exclusively inhibited by all three KTI-C inhibitors PI1410, 
PI5446 and PI420 with IC50 values of 1.59 µM, 1.01 µM 
and 1.28 µM, respectively.
Discussion
Sequencing 9,600 randomly selected cDNA clones from 
mature potato tuber tissue of ten cultivars yielded 175 
cDNA clones coding for various enzyme inhibitors accord-
ing to sequence similarity. The overall transcript frequency 
of inhibitors was 1.8 %, which is in the same order of 
magnitude as previously observed in 1,600 cDNA clones 
from tubers of cultivars Provita and Saturna (Heibges et al. 
2003a). The number of inhibitors isolated from individual 
cultivars varied widely, from three in cv Elfe to thirty-one 
in cv Solara, indicating large variation of inhibitor tran-
script levels, which could result from genotypic differ-
ences or different physiological states of the tubers used for 
library construction. Consistent with previous observations 
(Heibges et al. 2003a) the majority of all inhibitors slightly 
differed from sequences described in GenBank. The 120 
unique nucleotide sequences matched to 31 loci on 10 of 
the 12 potato chromosomes. The number of coding loci 
could be smaller, as some inhibitors matched with simi-
lar high scores to more than one locus. This indicates that 
many sequence variants were allelic. In particular, the 59 
KTI’s in groups A, B and C originated from only six loci, 
confirming the large allelic diversity of these genes.
To test whether structural variation is accompanied by 
functional diversification, we selected 29 representatives 
of various inhibitor classes for heterologous expression 
in the yeast P. pastoris. Twenty-three inhibitors could be 
expressed in soluble form and purified in sufficient quan-
tity, mostly KTI’s and PIN’s. The recombinant proteins 
were evaluated for in vitro enzyme inhibitory functions. 
Four purified, soluble inhibitor proteins (PI6033, PI0875, 
PI6362, PI0234) did not show any biological activity, nei-
ther against trypsin, the most commonly used enzyme for 
protease inhibition assays, nor any of the other enzymes 
tested. These proteins might have folded incorrectly or 
Fig. 2  Purification of the PI1410 fusion protein from P. pastoris cul-
ture media by affinity chromatography. a Coomassie stained SDS-
PAGE. Lane 1, P. pastoris culture media supernatant after 72 h induc-
tion of PI1410 expression by methanol. Lane 2, proteins precipitated 
with 40 % Ammonium sulfate from P. pastoris culture media. Lane 
3, purified and concentrated PI1410 inhibitor protein. b Western blot 
analysis. Lane 1, purified and concentrated PI1410 inhibitor protein 
following incubation with anti-myc-tag antibody. M molecular weight 
standards
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lacked components required for activity or their activity 
spectrum is completely different from the one covered in 
our study.
The remaining nineteen proteins inhibited with differ-
ent efficiency trypsin, the pharmacological important pro-
teases pig pancreatic elastase, human β-secretase (BACE-
1), human cathepsin K, and human HIV-1 protease, and 
potato 5-lipoxygenase. Trypsin and elastase are digestive 
proteases of insects that were previously shown to be tar-
geted by plant PIs in the context of plant defense against 
herbivores (Hartl et al. 2011; Major and Constabel 2008; 
Turra et al. 2009). Among the tested KTI’s trypsin was 
effectively inhibited only by group B inhibitors, whereas 
group A and C KTI’s showed weak or no trypsin inhibi-
tion. This contrasts a previous study (Heibges et al. 2003b) 
where both A and B KTIs inhibited trypsin when the fusion 
proteins were expressed in the fission yeast S. pombe. The 
discrepancies may be the consequence of the different het-
erologous expression systems and tags used. The KTI-A 
inhibitor constructs expressed in P. pastoris might have 
been non-functional due to incorrect protein folding or lack 
of disulfide bridge formation. In addition to trypsin, four 
of ten biologically active KTI-B proteins inhibited BACE-
1, demonstrating functional diversity within this group of 
allelic sequences. In agreement with previous functional 
studies (Glaczinski et al. 2002; Heibges et al. 2003b) 
trypsin inhibition by KTI’s in group C was low or even 
absent, which is likely due to a different substrate speci-
ficity. The three KTI’s in group C were biologically active 
since they all inhibited cathepsin K and potato 5-lipoxy-
genase. In addition, the KTI-C inhibitor PI5446 showed 
inhibitory properties on BACE-1. This functional differ-
ence presumably reflects the sequence diversity within the 
KTI-C family. The KTI group C proteins inhibited most 
effectively the cysteine protease cathepsin K, suggesting 
cysteine proteases as their main targets, although they show 
no homology to known cysteine protease inhibitor super-
families (Bevec et al. 1996; Turk and Bode 1991). Further 
functions beyond protease inhibition are possible. Besides 
the newly identified inhibition of potato 5-lipoxygenase, 
KTI group C proteins have been found to inhibit in vitro 
soluble potato tuber invertase. KTI-C inhibitor PI4202 is 
identical to these putative invertase inhibitors characterized 
previously (Glaczinski et al. 2002).
Besides the serine protease trypsin, the potato proteinase 
inhibitor I (PIN I) PI6013 inhibited the cysteine protease 
cathepsin K and the aspartyl protease HIV-1. This PIN I 
protein seems to have multiple specificities. Previous stud-
ies had revealed high inter- and intra-specific structural and 
functional diversity among the PIN I family (Jorgensen 
Table 2  In vitro inhibition of proteases and lipoxygenase by heterologous expressed potato tuber protease inhibitors
a
  % Inhibition at a molar ratio 2:1 of inhibitor: trypsin













KTI-A PI9070 9 – – – – –
KTI-A PI4063 6 – – – – –
KTI-B PI4435 62 – – – – –
KTI-B PI4587 53 – + (IC50 0.81 µM) – – –
KTI-B PI8234 59 – + (IC50 0.4 µM) – – –
KTI-B PI2112 65 – + (IC50 0.36 µM) – – –
KTI-B PI2568 55 – – – – –
KTI-B PI5887 38 – + (IC50 0.47 µM) – – –
KTI-B PI8383 61 – – – – –
KTI-B PI5918 83 – – – – –
KTI-B PI8311 16 – – – – –
KTI-B PI9142 53 – – – – –
KTI-C PI1410 0 – – + (IC50 0.09 µM) + (IC50 1.59 µM) –
KTI-C PI5446 5 – + (IC50 0.72 µM) + (IC50 0.08 µM) + (IC50 1.01 µM) –
KTI-C PI4202 5 – – + (IC50 0.02 µM) + (IC50 1.28 µM) –
PIN I PI6013 44 – – + (IC50 0.77 µM) – + (IC 50 
0.67 µM)
PIN II PI4434 43 + (IC50 0.67 µM) – – – –
PIN II PI6669 87 + (IC50 0.97 µM) – – – –
PMEI PI7531 10 – – – – –
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et al. 2011; Turra et al. 2009). Native PIN I proteins have 
been suggested to occur as hexameric protein complexes 
in which every monomer represents a functional unit (van 
den Broek et al. 2004). PIN I monomers interact with the 
reactive center of a protease by a constrained loop pro-
truding from the surface of the molecule (Mcphalen and 
James 1988; Mcphalen et al. 1985). Substrate specificity 
is supposed to be determined by the amino acid composi-
tion of the reactive loop. A lysine residue may interact with 
trypsin-like proteases while leucine or methionine at the 
same position in the reactive loop will bind to and inhibit 
proteases specific for hydrophobic side chains such as 
chymotrypsin (Jorgensen et al. 2011; van den Broek et al. 
2004). PI6013 possesses an alanine residue at the corre-
sponding position in the reactive loop, which might explain 
the different substrate specificities of this inhibitor.
Two representatives from the potato proteinase inhibitor 
family II (PIN II) inhibited trypsin and in addition elastase 
from pig pancreas (PPE). The activity of human leukocyte 
elastase was not affected. Members of the PIN II family are 
mainly found in the Solanaceae. Initially characterized in 
potato tubers they have been detected in leaves, flowers, 
fruits and phloem tissue of different Solanaceous species 
(Christeller and Laing 2005; Iwasaki et al. 1971; Miller 
et al. 2000; Pearce et al. 1993, 1988). Interestingly, PPE 
has been used as model system in several pharmacologi-
cal screening assays for finding human leucocyte elastase 
(HLE) inhibitors. PIN II proteins function in planta pre-
sumably in defense reactions in response to the attack of 
herbivores and other pests (Hartl et al. 2010). The PIN II 
proteins PI4434 and PI6669 may act on insect gut proteases 
as part of constitutive defense mechanisms against herbi-
vores in potato tubers and other tissues.
Diversity and abundance of plant protease inhibitors 
make them excellent sources for discovering novel enzyme 
inhibitors with specific pharmacological effects. Previous 
studies revealed several plant proteinase inhibitors act-
ing on proteases involved in blood coagulation, fibrinoly-
sis, inflammation or tumor cell proliferation [reviewed in 
(Oliva and Sampaio 2009) and (Fear et al. 2007)]. The ther-
apeutic effect of a soybean derived Bowman–Birk inhibitor 
(BBI) in inflammatory diseases and cancer has been shown 
in several completed or ongoing human trials (Safavi and 
Rostami 2012). To the best of our knowledge, this is the 
first report of plant-derived Kunitz-type inhibitors with 
inhibitory activity on BACE-1 and cathepsin K, and a PIN I 
protein restricting HIV-1 protease activity. Human BACE-1 
catalyzes the initial step in amyloidogenic metabolism of 
the large transmembrane amyloid precursor protein (APP) 
leading to the release of the amyloid β-peptide (Aβ) (Sinha 
and Lieberburg 1999). Aβ was identified as the main con-
stituent of extracellular plaques in human brain which are 
characteristic for Alzheimer’s disease (Glenner and Wong 
1984; Masters et al. 1985). Inhibition of BACE-1 could 
potentially reduce the extent of amyloid plaques and slow 
down or reverse the progression of the disease. Hence, the 
design of selective inhibitors of BACE-1 has been the tar-
get of intensive pharmaceutical development (Ghosh et al. 
2008). Clinical effective BACE-1 inhibitors require high 
specificity and the ability to penetrate the blood–brain bar-
rier and neuronal membranes. The KTI-B inhibitors of 
BACE-1 in our set exhibited higher substrate specificity 
compared to the KTI-C inhibitor, which qualifies them as 
lead structures for further research on drug development. 
The tested KTI-C inhibitors (PI5446, PI1410 and PI4202) 
were the most effective inhibitors of cathepsin K in our 
experiments. Cathepsin K is a lysosomal cysteine protease 
involved in osteoclast-mediated bone resorption. Inhibition 
of cathepsin K represents a potentially effective therapeutic 
approach for treating diseases characterized by excessive 
bone resorption, such as osteoporosis. KTI-C inhibitors 
showed a broader range of biological activity than KTI-B 
inhibitors, since members of this group inhibited 5-lipox-
ygenase in addition to BACE-1 and Cathepsin K. Never-
theless, the KTI-C inhibitors present potent starting points 
for protein engineering with the aim to increase substrate 
specificity. The same is true for the PINI inhibitor PI6013, 
which showed similar inhibitory properties on cathepsin K 
as well as HIV-protease, which is involved in virus prolif-
eration (Sundquist and Kräusslich 2012).
The biological activity of potato KTIs is not limited to 
protease inhibition. Besides inhibition of invertase by spe-
cific members of the KTI-C family (Glaczinski et al. 2002), 
we demonstrated in this study that three KTI-C recombinant 
proteins inhibit potato 5-lipoxygenase. Plant lipoxygenases 
(LOX) are key enzymes in the biosynthesis of oxylipins, 
which play important roles in plant defense and develop-
ment (Feussner and Wasternack 2002). The substrates of 
LOX are polyunsaturated fatty acids. The 5-LOX activity 
converts arachidonic acid in 5-Hydroperoxyeicosatetraenoic 
acid (5-HPETE), an intermediate in the biosynthesis of leu-
kotrienes and other eicosanoids. The 5-LOX pathway is not 
only relevant for plant defense (Bostock et al. 1992) but also 
for inflammatory processes in humans leading to patholo-
gies such as asthma and allergic reactions (Harizi and 
Gualde 2004). 5-LOX inhibitors have, therefore, been the 
targets of drug development (Williams and Spector 2009). 
The inhibition of LOX also opens up new possibilities for 
the in planta function of KTIs beyond protease inhibition. 
The new inhibitory functions discovered in this study might 
be just the tip of an iceberg, as our functional screens cov-
ered only a small fraction of enzymatic reactions. Screen-
ing recombinant potato inhibitors on additional classes of 
enzymes might reveal further biological activities.
In conclusion, we provide novel insights into the struc-
tural and functional diversity of proteinaceous inhibitors 
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of potato tubers, which have potential for biotechnologi-
cal applications. We identified inhibitors for proteases 
involved in severe human diseases, which may be used 
in drug development. Further studies of the mechanism 
of action and binding of natural inhibitors can provide 
leads for developing therapeutic agents against human 
diseases. The discovery of LOX inhibition by certain 
Kunitz-type inhibitors opens new possibilities for the 
in vivo functional role of this abundant class of tuber 
proteins.
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